Regain Therapeutics Sweden AB

ABIn liquidation

Org 5592743016Economic activity was not specified by tax authority · NACE 0000Est. 20200 employees

Overview Financials People & ownership Related companies

Regain Therapeutics Sweden AB is a Swedish AB, operating in the Huvudnäring okänd sector. Incorporated in 2020, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

-1769% vs 2023

Equity ratio

-105.7%

Financial strength

Net profit 2024

SEK -2M

-1769% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -2M	-1769%
Net profit	SEK -2M	-1769%
Total assets	SEK 1,8M	+0%
Equity	SEK -1,9M	-1548%
Employees	0	—

Contact

Address

gustav.kling@carler.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Regain Therapeutics Sweden AB?

Regain Therapeutics Sweden AB is registered with Bolagsverket / SCB under Org 5592743016.

Who is the CEO of Regain Therapeutics Sweden AB?

Kariem Ezzat Ahmed is Chief Executive Officer of Regain Therapeutics Sweden AB, in role since 2022.

Who is the chairman of Regain Therapeutics Sweden AB?

Nils Henrik Kristoffer Svensson chairs the board of Regain Therapeutics Sweden AB, in role since 2020.

Regain Therapeutics Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Regain Therapeutics Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Regain Therapeutics Sweden AB